SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C2 - Parkinson's Disease Update

Event Time: Saturday April 22, 2017 8:00 am to 10:00 am
Topic(s): Movement Disorders
Director(s): Melissa Nirenberg MD, PhD, FAAN
Description: This program will provide participants with a global overview of Parkinson's disease, including the latest information about pathophysiology, genetic and environmental risk factors, biomarkers, and clinical phenomenology. Faculty will focus on the evidence-based management of motor symptoms, nonmotor symptoms, and complications of dopaminergic therapy, including the role of new and emerging medical and surgical treatments.
Completion Message: Participants should have a broad understanding of Parkinson's disease, including pathophysiology, genetics, biomarkers, risk factors, motor and nonmotor symptoms, complications of dopaminergic therapy, and evidence-based medical and surgical therapies.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care, Practice-Based Learning and Improvement

Program Speakers - Tentative

Start/End Time Title Faculty
8:00 AM - 8:50 AM Overview of Parkinson's Disease: Part I Hubert Fernandez MD, FAAN 
8:50 AM - 9:00 AM Questions and Answers Hubert Fernandez MD, FAAN 
9:00 AM - 9:50 AM Overview of Parkinson's Disease: Part II Melissa Nirenberg MD, PhD, FAAN 
9:50 AM - 10:00 AM Questions and Answers Melissa Nirenberg MD, PhD, FAAN 

Disclosures

Speaker Disclosure
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received honoraria from Prime Education Inc, Carling Communications, Medscape, as a speaker in CME events. Dr. Fernandez has received honoraria from Biogen, GE Health Care, Lundbeck, Merz Pharmaceuticals and Pfizer Pharmaceuticals, as a consultant.. Dr. Fernandez has received a stipend from International Parkinson and Movement Disorders Society for serving as Medical Editor of the MDS Web Site. . Dr. Fernandez has received royalty payments from Demos Publishing for serving as a book author/editor. Dr. Fernandez has received research support from Abbvie, Acadia, Auspex/Teva, Biotie/Acorda Therapeutics, Civitas, Kyowa/Prostrakan, Michael J. Fox Foundation, Movement Disorders Society, NIH/NINDS, Parkinson Study Group, Rhythm, Synosia, but has no owner interest in any pharmaceutical company. NIH/NINDS, Parkinson Study Group, Rhythm, Synosia, Teva, but has no owner interest in any pharmaceutical company. .

Melissa J. Nirenberg, MD, PhD, FAAN Dr. Nirenberg has nothing to disclose.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C4 Hyperkinetic Movement Disorders: Videodiagnosis and Treatment Steven Frucht MD
9:30 AM-11:30 AM
C14 Parkinson's Disease Update Melissa Nirenberg MD, PhD, FAAN
1:30 PM-3:30 PM
C23 Diagnosis and Treatment of Functional Movement Disorders Mark Hallett MD, FAAN

Sunday April 22, 2018

7:00 AM-9:00 AM
C24 Hot Topics and Controversies in Parkinson's Disease Melissa Nirenberg MD, PhD, FAAN
1:00 PM-3:00 PM
C36 Nonmotor Manifestations of Parkinson's Disease I Charles Adler MD, PhD, FAAN
3:30 PM-5:30 PM
C50 Nonmotor Manifestations of Parkinson's Disease II Charles Adler MD, PhD, FAAN

Monday April 23, 2018

7:00 AM-9:00 AM
C65 Video EEG: Name That Spell Amy Crepeau MD
C58 Balance and Gait Disorders Bastiaan Bloem MD, PhD
1:00 PM-3:00 PM
C67 Evaluating Tremor in the Office Vicki Shanker MD

Wednesday April 25, 2018

7:00 AM-9:00 AM
C139 Paroxysmal Movement Disorders Kailash Bhatia MD, FAAN
1:00 PM-5:30 PM
C158 Clinical Uses of Botulinum Toxin for Dystonia Skills Workshop Diego Torres-Russotto MD, FAAN

Thursday April 26, 2018

7:00 AM-9:00 AM
C176 The Dystonia: Diagnosis, Treatment and Update on Etiologies Rachel Saunders-Pullman MD
1:00 PM-3:00 PM
C186 Cerebellar and Afferent Ataxias: Diagnosis and Management Massimo Pandolfo MD, FAAN
3:30 PM-5:30 PM
C208 Clinical Usefulness of Botulinum Toxin for Spasticity Skills Workshop Allison Brashear MD, MBA, FAAN
6:30 PM-9:30 PM
C212 Case Studies: Unusual Movement Disorders Kailash Bhatia MD, FAAN

MEMBER LOG IN

Forgot Password?